Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca, China
AstraZeneca shareholders say they need clarity on China investigations
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one of its key markets.
AstraZeneca sales jump despite troubles in China
UK drugmaker AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter of 2024. AstraZeneca ’s $14.
AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.
AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
AstraZeneca shares rise as China probe update reassures
AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising investor hopes that the impact of several probes in the country could be minor and leading its shares to rise about 5%.
1h
Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse
AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
1d
on MSN
Drugmaker AstraZeneca flags possible $4.5 million Chinese tax fine
AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...
FierceBiotech
1d
AstraZeneca CEO defends 'fantastic' Alexion buyout in face of $753M hit from dropped drug
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...
1d
on MSN
AstraZeneca Expects Further Sales, Earnings Growth After Results Beat Market Views
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
1d
AstraZeneca CEO: UK must improve investment environment
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
1d
on MSN
AstraZeneca Boss Says UK ‘Isn’t the Worst Place’ to Invest
The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...
9h
AstraZeneca (AZN) Gets a Hold from Deutsche Bank
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...
1d
Pharmaceutical giant AstraZeneca faces potential fines in China over import taxes
AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with ...
Daily
7h
AstraZeneca Gets CDSCO Panel Nod To study Baxdrostat Tablets and Dapagliflozin Tablets
Baxdrostat is a drug that reduces aldosterone levels in the body to treat high blood pressure and other conditions. It's an ...
22h
on MSN
Why AstraZeneca Topped the Market on Thursday
A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday.
1d
AstraZeneca 'very disappointed' after scrapping £450m vaccine plant in Liverpool
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
China
Bank of England
United Kingdom
Leon Wang
FTSE 100
Feedback